Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow
Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow
复制标题
DOI：
10.3816/clm.2004.n.012
复制
发表时间：
2004-06-01
期刊：
影响因子：
--
通讯作者：
Schuster, SJ
中科院分区：
文献类型：
--
作者：
Elstrom, RL;Tsai, DE;Schuster, SJ
[F-18]氟脱氧葡萄糖（FDG）正电子发射断层扫描（PET）越来越多地用于淋巴瘤的临床分期和治疗反应的评估。我们报告一例典型霍奇金淋巴瘤患者，肿瘤和骨髓明显摄取FDG，提示淋巴瘤弥漫性骨髓受累。然而，髂嵴骨髓检查显示明显的骨髓增生，没有淋巴瘤累及的证据。我们讨论的意义解释的FDG-PET显像骨髓淋巴瘤。
[F-18]Fluorodeoxyglucose (FDG) positron emission tomography (PET) is increasingly used for the clinical staging of lymphomas and for assessment of response to therapy. We report the case of a woman with classic Hodgkin's lymphoma who had marked FDG uptake by tumor and bone marrow suggestive of diffuse marrow involvement by lymphoma. However, iliac crest bone marrow examination showed marked myeloid hyperplasia without evidence of lymphoma involvement. We discuss the implications for interpretation of FDG-PET imaging of bone marrow in lymphomas.